Osman, S. T., Elzahhar, P. A., Hakim, M. A., Sanni, A., Hamdy, N. A., Purba, W. T., . . . El‐Yazbi, A. F. (2026). Repurposing SGLT2 and DPP‐4 inhibitors for mild cognitive impairment in type 2 diabetes mellitus: Insights from proteomics, target prediction and molecular docking. Wiley. https://doi.org/10.1111/bph.70331
Chicago-Zitierstil (17. Ausg.)Osman, Shams T., et al. Repurposing SGLT2 and DPP‐4 Inhibitors for Mild Cognitive Impairment in Type 2 Diabetes Mellitus: Insights from Proteomics, Target Prediction and Molecular Docking. Wiley, 2026. https://doi.org/10.1111/bph.70331.
MLA-Zitierstil (9. Ausg.)Osman, Shams T., et al. Repurposing SGLT2 and DPP‐4 Inhibitors for Mild Cognitive Impairment in Type 2 Diabetes Mellitus: Insights from Proteomics, Target Prediction and Molecular Docking. Wiley, 2026. https://doi.org/10.1111/bph.70331.